0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Endocrinology and Metabolism Market Research Report 2026
Published Date: 2026-03-30
|
Report Code: QYRE-Auto-13U17438
Home | Market Reports
Global Endocrinology and Metabolism Market Research Report 2024
BUY CHAPTERS

Global Endocrinology and Metabolism Market Research Report 2026

Code: QYRE-Auto-13U17438
Report
2026-03-30
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Endocrinology and Metabolism Market Size

The global Endocrinology and Metabolism market was valued at US$ 105550 million in 2025 and is anticipated to reach US$ 219550 million by 2032, at a CAGR of 11.2% from 2026 to 2032.

Endocrinology and Metabolism Market

Endocrinology and Metabolism Market

Endocrinology is the internal medicine subspecialty dedicated to the diagnosis and care of diseases and conditions related to the endocrine glands, hormones, and metabolism, the body’s physical and chemical processes to use energy or convert it for use. These diseases and conditions include type 1 and type 2 diabetes; obesity; conditions of the pituitary, thyroid, parathyroid, and adrenal glands; and metabolic disorders.
The rising frequency of endocrine problems, including diabetes, thyroid disorders, and hormonal imbalances, is another major factor driving the endocrinology and metabolism market. Sedentary lifestyles, bad eating habits, rising obesity rates, and an aging population all contribute to the growing global burden of endocrine illnesses. As the frequency and prevalence of these problems rise, so does the demand for diagnostic tests, medicines, and treatment procedures that address endocrine and metabolic abnormalities. This spike in demand opens up attractive prospects for market players to offer innovative products and services to meet the growing healthcare needs of people with endocrine diseases.
This report delivers a comprehensive overview of the global Endocrinology and Metabolism market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Endocrinology and Metabolism. The Endocrinology and Metabolism market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Endocrinology and Metabolism market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Endocrinology and Metabolism manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Endocrinology and Metabolism Market Report

Report Metric Details
Report Name Endocrinology and Metabolism Market
Accounted market size in 2025 US$ 105550 million
Forecasted market size in 2032 US$ 219550 million
CAGR 11.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Diabetes Drugs
  • HGH
  • Thyroid Hormone Disorders
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Endocrinology and Metabolism companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Endocrinology and Metabolism Market growing?

Ans: The Endocrinology and Metabolism Market witnessing a CAGR of 11.2% during the forecast period 2026-2032.

What is the Endocrinology and Metabolism Market size in 2032?

Ans: The Endocrinology and Metabolism Market size in 2032 will be US$ 219550 million.

Who are the main players in the Endocrinology and Metabolism Market report?

Ans: The main players in the Endocrinology and Metabolism Market are Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma

What are the Application segmentation covered in the Endocrinology and Metabolism Market report?

Ans: The Applications covered in the Endocrinology and Metabolism Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Endocrinology and Metabolism Market report?

Ans: The Types covered in the Endocrinology and Metabolism Market report are Diabetes Drugs, HGH, Thyroid Hormone Disorders, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrinology and Metabolism Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Diabetes Drugs
1.2.3 HGH
1.2.4 Thyroid Hormone Disorders
1.2.5 Others
1.3 Market by Application
1.3.1 Global Endocrinology and Metabolism Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrinology and Metabolism Market Perspective (2021–2032)
2.2 Global Endocrinology and Metabolism Growth Trends by Region
2.2.1 Global Endocrinology and Metabolism Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Endocrinology and Metabolism Historic Market Size by Region (2021–2026)
2.2.3 Endocrinology and Metabolism Forecasted Market Size by Region (2027–2032)
2.3 Endocrinology and Metabolism Market Dynamics
2.3.1 Endocrinology and Metabolism Industry Trends
2.3.2 Endocrinology and Metabolism Market Drivers
2.3.3 Endocrinology and Metabolism Market Challenges
2.3.4 Endocrinology and Metabolism Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrinology and Metabolism Players by Revenue
3.1.1 Global Top Endocrinology and Metabolism Players by Revenue (2021–2026)
3.1.2 Global Endocrinology and Metabolism Revenue Market Share by Players (2021–2026)
3.2 Global Top Endocrinology and Metabolism Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Endocrinology and Metabolism Revenue
3.4 Global Endocrinology and Metabolism Market Concentration Ratio
3.4.1 Global Endocrinology and Metabolism Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrinology and Metabolism Revenue in 2025
3.5 Global Key Players of Endocrinology and Metabolism Head Offices and Areas Served
3.6 Global Key Players of Endocrinology and Metabolism, Products and Applications
3.7 Global Key Players of Endocrinology and Metabolism, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Endocrinology and Metabolism Breakdown Data by Type
4.1 Global Endocrinology and Metabolism Historic Market Size by Type (2021–2026)
4.2 Global Endocrinology and Metabolism Forecasted Market Size by Type (2027–2032)
5 Endocrinology and Metabolism Breakdown Data by Application
5.1 Global Endocrinology and Metabolism Historic Market Size by Application (2021–2026)
5.2 Global Endocrinology and Metabolism Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Endocrinology and Metabolism Market Size (2021–2032)
6.2 North America Endocrinology and Metabolism Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Endocrinology and Metabolism Market Size by Country (2021–2026)
6.4 North America Endocrinology and Metabolism Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrinology and Metabolism Market Size (2021–2032)
7.2 Europe Endocrinology and Metabolism Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Endocrinology and Metabolism Market Size by Country (2021–2026)
7.4 Europe Endocrinology and Metabolism Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Endocrinology and Metabolism Market Size (2021–2032)
8.2 Asia-Pacific Endocrinology and Metabolism Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Endocrinology and Metabolism Market Size by Region (2021–2026)
8.4 Asia-Pacific Endocrinology and Metabolism Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Endocrinology and Metabolism Market Size (2021–2032)
9.2 Latin America Endocrinology and Metabolism Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Endocrinology and Metabolism Market Size by Country (2021–2026)
9.4 Latin America Endocrinology and Metabolism Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrinology and Metabolism Market Size (2021–2032)
10.2 Middle East & Africa Endocrinology and Metabolism Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Endocrinology and Metabolism Market Size by Country (2021–2026)
10.4 Middle East & Africa Endocrinology and Metabolism Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Endocrinology and Metabolism Introduction
11.1.4 Abbott Laboratories Revenue in Endocrinology and Metabolism Business (2021–2026)
11.1.5 Abbott Laboratories Recent Development
11.2 Acerus Pharmaceuticals Corp.
11.2.1 Acerus Pharmaceuticals Corp. Company Details
11.2.2 Acerus Pharmaceuticals Corp. Business Overview
11.2.3 Acerus Pharmaceuticals Corp. Endocrinology and Metabolism Introduction
11.2.4 Acerus Pharmaceuticals Corp. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.2.5 Acerus Pharmaceuticals Corp. Recent Development
11.3 Ascendis Pharma AS
11.3.1 Ascendis Pharma AS Company Details
11.3.2 Ascendis Pharma AS Business Overview
11.3.3 Ascendis Pharma AS Endocrinology and Metabolism Introduction
11.3.4 Ascendis Pharma AS Revenue in Endocrinology and Metabolism Business (2021–2026)
11.3.5 Ascendis Pharma AS Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Details
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Endocrinology and Metabolism Introduction
11.4.4 Bayer AG Revenue in Endocrinology and Metabolism Business (2021–2026)
11.4.5 Bayer AG Recent Development
11.5 Beta Cell NV
11.5.1 Beta Cell NV Company Details
11.5.2 Beta Cell NV Business Overview
11.5.3 Beta Cell NV Endocrinology and Metabolism Introduction
11.5.4 Beta Cell NV Revenue in Endocrinology and Metabolism Business (2021–2026)
11.5.5 Beta Cell NV Recent Development
11.6 Biocon Ltd.
11.6.1 Biocon Ltd. Company Details
11.6.2 Biocon Ltd. Business Overview
11.6.3 Biocon Ltd. Endocrinology and Metabolism Introduction
11.6.4 Biocon Ltd. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.6.5 Biocon Ltd. Recent Development
11.7 Eli Lilly and Co.
11.7.1 Eli Lilly and Co. Company Details
11.7.2 Eli Lilly and Co. Business Overview
11.7.3 Eli Lilly and Co. Endocrinology and Metabolism Introduction
11.7.4 Eli Lilly and Co. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.7.5 Eli Lilly and Co. Recent Development
11.8 Endo International Plc
11.8.1 Endo International Plc Company Details
11.8.2 Endo International Plc Business Overview
11.8.3 Endo International Plc Endocrinology and Metabolism Introduction
11.8.4 Endo International Plc Revenue in Endocrinology and Metabolism Business (2021–2026)
11.8.5 Endo International Plc Recent Development
11.9 Hoffmann La Roche Ltd.
11.9.1 Hoffmann La Roche Ltd. Company Details
11.9.2 Hoffmann La Roche Ltd. Business Overview
11.9.3 Hoffmann La Roche Ltd. Endocrinology and Metabolism Introduction
11.9.4 Hoffmann La Roche Ltd. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.9.5 Hoffmann La Roche Ltd. Recent Development
11.10 GlaxoSmithKline Plc
11.10.1 GlaxoSmithKline Plc Company Details
11.10.2 GlaxoSmithKline Plc Business Overview
11.10.3 GlaxoSmithKline Plc Endocrinology and Metabolism Introduction
11.10.4 GlaxoSmithKline Plc Revenue in Endocrinology and Metabolism Business (2021–2026)
11.10.5 GlaxoSmithKline Plc Recent Development
11.11 Hanmi Pharm Co. Ltd.
11.11.1 Hanmi Pharm Co. Ltd. Company Details
11.11.2 Hanmi Pharm Co. Ltd. Business Overview
11.11.3 Hanmi Pharm Co. Ltd. Endocrinology and Metabolism Introduction
11.11.4 Hanmi Pharm Co. Ltd. Revenue in Endocrinology and Metabolism Business (2021–2026)
11.11.5 Hanmi Pharm Co. Ltd. Recent Development
11.12 Ipsen Pharma
11.12.1 Ipsen Pharma Company Details
11.12.2 Ipsen Pharma Business Overview
11.12.3 Ipsen Pharma Endocrinology and Metabolism Introduction
11.12.4 Ipsen Pharma Revenue in Endocrinology and Metabolism Business (2021–2026)
11.12.5 Ipsen Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Endocrinology and Metabolism Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Diabetes Drugs
 Table 3. Key Players of HGH
 Table 4. Key Players of Thyroid Hormone Disorders
 Table 5. Key Players of Others
 Table 6. Global Endocrinology and Metabolism Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Endocrinology and Metabolism Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Endocrinology and Metabolism Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Endocrinology and Metabolism Market Share by Region (2021–2026)
 Table 10. Global Endocrinology and Metabolism Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Endocrinology and Metabolism Market Share by Region (2027–2032)
 Table 12. Endocrinology and Metabolism Market Trends
 Table 13. Endocrinology and Metabolism Market Drivers
 Table 14. Endocrinology and Metabolism Market Challenges
 Table 15. Endocrinology and Metabolism Market Restraints
 Table 16. Global Endocrinology and Metabolism Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Endocrinology and Metabolism Market Share by Players (2021–2026)
 Table 18. Global Top Endocrinology and Metabolism Players by Tier (Tier 1, Tier 2, and Tier 3), based on Endocrinology and Metabolism Revenue, 2025
 Table 19. Ranking of Global Top Endocrinology and Metabolism Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Endocrinology and Metabolism Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Endocrinology and Metabolism, Headquarters and Area Served
 Table 22. Global Key Players of Endocrinology and Metabolism, Products and Applications
 Table 23. Global Key Players of Endocrinology and Metabolism, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Endocrinology and Metabolism Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Endocrinology and Metabolism Revenue Market Share by Type (2021–2026)
 Table 27. Global Endocrinology and Metabolism Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Endocrinology and Metabolism Revenue Market Share by Type (2027–2032)
 Table 29. Global Endocrinology and Metabolism Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Endocrinology and Metabolism Revenue Market Share by Application (2021–2026)
 Table 31. Global Endocrinology and Metabolism Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Endocrinology and Metabolism Revenue Market Share by Application (2027–2032)
 Table 33. North America Endocrinology and Metabolism Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Endocrinology and Metabolism Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Endocrinology and Metabolism Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Endocrinology and Metabolism Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Endocrinology and Metabolism Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Endocrinology and Metabolism Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Endocrinology and Metabolism Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Endocrinology and Metabolism Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Endocrinology and Metabolism Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Endocrinology and Metabolism Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Endocrinology and Metabolism Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Endocrinology and Metabolism Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Endocrinology and Metabolism Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Endocrinology and Metabolism Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Endocrinology and Metabolism Market Size by Country (US$ Million), 2027–2032
 Table 48. Abbott Laboratories Company Details
 Table 49. Abbott Laboratories Business Overview
 Table 50. Abbott Laboratories Endocrinology and Metabolism Product
 Table 51. Abbott Laboratories Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 52. Abbott Laboratories Recent Development
 Table 53. Acerus Pharmaceuticals Corp. Company Details
 Table 54. Acerus Pharmaceuticals Corp. Business Overview
 Table 55. Acerus Pharmaceuticals Corp. Endocrinology and Metabolism Product
 Table 56. Acerus Pharmaceuticals Corp. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 57. Acerus Pharmaceuticals Corp. Recent Development
 Table 58. Ascendis Pharma AS Company Details
 Table 59. Ascendis Pharma AS Business Overview
 Table 60. Ascendis Pharma AS Endocrinology and Metabolism Product
 Table 61. Ascendis Pharma AS Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 62. Ascendis Pharma AS Recent Development
 Table 63. Bayer AG Company Details
 Table 64. Bayer AG Business Overview
 Table 65. Bayer AG Endocrinology and Metabolism Product
 Table 66. Bayer AG Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 67. Bayer AG Recent Development
 Table 68. Beta Cell NV Company Details
 Table 69. Beta Cell NV Business Overview
 Table 70. Beta Cell NV Endocrinology and Metabolism Product
 Table 71. Beta Cell NV Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 72. Beta Cell NV Recent Development
 Table 73. Biocon Ltd. Company Details
 Table 74. Biocon Ltd. Business Overview
 Table 75. Biocon Ltd. Endocrinology and Metabolism Product
 Table 76. Biocon Ltd. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 77. Biocon Ltd. Recent Development
 Table 78. Eli Lilly and Co. Company Details
 Table 79. Eli Lilly and Co. Business Overview
 Table 80. Eli Lilly and Co. Endocrinology and Metabolism Product
 Table 81. Eli Lilly and Co. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 82. Eli Lilly and Co. Recent Development
 Table 83. Endo International Plc Company Details
 Table 84. Endo International Plc Business Overview
 Table 85. Endo International Plc Endocrinology and Metabolism Product
 Table 86. Endo International Plc Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 87. Endo International Plc Recent Development
 Table 88. Hoffmann La Roche Ltd. Company Details
 Table 89. Hoffmann La Roche Ltd. Business Overview
 Table 90. Hoffmann La Roche Ltd. Endocrinology and Metabolism Product
 Table 91. Hoffmann La Roche Ltd. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 92. Hoffmann La Roche Ltd. Recent Development
 Table 93. GlaxoSmithKline Plc Company Details
 Table 94. GlaxoSmithKline Plc Business Overview
 Table 95. GlaxoSmithKline Plc Endocrinology and Metabolism Product
 Table 96. GlaxoSmithKline Plc Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 97. GlaxoSmithKline Plc Recent Development
 Table 98. Hanmi Pharm Co. Ltd. Company Details
 Table 99. Hanmi Pharm Co. Ltd. Business Overview
 Table 100. Hanmi Pharm Co. Ltd. Endocrinology and Metabolism Product
 Table 101. Hanmi Pharm Co. Ltd. Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 102. Hanmi Pharm Co. Ltd. Recent Development
 Table 103. Ipsen Pharma Company Details
 Table 104. Ipsen Pharma Business Overview
 Table 105. Ipsen Pharma Endocrinology and Metabolism Product
 Table 106. Ipsen Pharma Revenue in Endocrinology and Metabolism Business (US$ Million), 2021–2026
 Table 107. Ipsen Pharma Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Endocrinology and Metabolism Picture
 Figure 2. Global Endocrinology and Metabolism Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Endocrinology and Metabolism Market Share by Type: 2025 vs 2032
 Figure 4. Diabetes Drugs Features
 Figure 5. HGH Features
 Figure 6. Thyroid Hormone Disorders Features
 Figure 7. Others Features
 Figure 8. Global Endocrinology and Metabolism Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Endocrinology and Metabolism Market Share by Application: 2025 vs 2032
 Figure 10. Hospital Pharmacies Case Studies
 Figure 11. Retail Pharmacies Case Studies
 Figure 12. Online Pharmacies Case Studies
 Figure 13. Endocrinology and Metabolism Report Years Considered
 Figure 14. Global Endocrinology and Metabolism Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Endocrinology and Metabolism Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Endocrinology and Metabolism Market Share by Region: 2025 vs 2032
 Figure 17. Global Endocrinology and Metabolism Market Share by Players in 2025
 Figure 18. Global Endocrinology and Metabolism Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Endocrinology and Metabolism Revenue in 2025
 Figure 20. North America Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Endocrinology and Metabolism Market Share by Country (2021–2032)
 Figure 22. United States Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Endocrinology and Metabolism Market Share by Country (2021–2032)
 Figure 26. Germany Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Endocrinology and Metabolism Market Share by Region (2021–2032)
 Figure 34. China Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Endocrinology and Metabolism Market Share by Country (2021–2032)
 Figure 42. Mexico Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Endocrinology and Metabolism Market Share by Country (2021–2032)
 Figure 46. Israel Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Endocrinology and Metabolism Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Abbott Laboratories Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 50. Acerus Pharmaceuticals Corp. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 51. Ascendis Pharma AS Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 52. Bayer AG Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 53. Beta Cell NV Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 54. Biocon Ltd. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 55. Eli Lilly and Co. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 56. Endo International Plc Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 57. Hoffmann La Roche Ltd. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 58. GlaxoSmithKline Plc Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 59. Hanmi Pharm Co. Ltd. Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 60. Ipsen Pharma Revenue Growth Rate in Endocrinology and Metabolism Business (2021–2026)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS